Carl W. Dieffenbach, National Institute of Allergy and Infectious Diseases and Gita Ramjee, South African Medical Research Council
A global clinical trial has been launched to reduce the cardiovascular disease risk factors among people living with HIV who are on antiretrovirals.
Lipitor is widely prescribed for cholesterol, but incorrect negative reports have seen its use decline slightly in Australia.
from www.shutterstock.com.au
Lipitor was approved by the government in 1997, and while under patent protection it was the highest-selling drug of all time with worldwide sales of more than US$12 billion a year.
Half a million fewer statins were dispensed to patients in the eight months following the Catalyst broadcasts.
Concept Photo/Shutterstock
A panel convened by medical journal BMJ to investigate whether it was right to correct rather than retract two pieces featuring a mistake about side effects from statins has endorsed the journal’s decision…
For 60 years, clinical trials have provided the gold standard of evidence for showing whether new treatments work and whether they are safe before they are rolled out on a large scale. Trials are used…
People who are questioning whether to continue taking statins should talk to a doctor.
Hilke Kurzke
After last week’s controversial Catalyst program on the ABC, some people may be wondering whether they should stop taking statins to lower their cholesterol. But before making such a decision, read this…
Statins have improved the quality of life for many people who would have otherwise suffered debilitating cardiovascular disease.
Mykl Roventine
Cardiovascular disease (heart attack and stroke) causes the most deaths in Western countries overall and the vast majority of premature deaths. Drugs known as statins have been the cornerstone of how we…
Anti-cholesterol drug Lipitor has come off patent and faces tough competition from generic versions.
The.Comedian/Flickr
Anti-cholesterol drug Lipitor® (atorvastatin) has been estimated to generate Pfizer revenues of more than $130bn worldwide. Australian taxpayers’ share of this is about $7bn, through subsidies from the…